Spots Global Cancer Trial Database for peposertib 100 mg
Every month we try and update this database with for peposertib 100 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | NCT03770689 | Locally Advance... | Peposertib 50 m... Peposertib 100 ... Peposertib 150 ... Peposertib 250 ... Capecitabine Radiotherapy (R... | 18 Years - | EMD Serono | |
Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | NCT03770689 | Locally Advance... | Peposertib 50 m... Peposertib 100 ... Peposertib 150 ... Peposertib 250 ... Capecitabine Radiotherapy (R... | 18 Years - | EMD Serono |